A rating of 90 puts Bausch Health Companies Inc (BHC) near the top of the Drug Manufacturers – Specialty & Generic industry according to InvestorsObserver. Bausch Health Companies Inc’s score of 90 means it scores higher than 90% of stocks in the industry. Bausch Health Companies Inc also received an overall rating of 49, putting it above 49% of all stocks. Drug Manufacturers – Specialty & Generic is ranked 143 out of the 148 industries.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 49 means the stock is more attractive than 49 percent of stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What’s Happening With Bausch Health Companies Inc Stock Today?
Bausch Health Companies Inc (BHC) stock has gained 0.96% while the S&P 500 is lower by -0.11% as of 11:00 AM on Wednesday, Dec 15. BHC is higher by $0.24 from the previous closing price of $24.49 on volume of 1,664,301 shares. Over the past year the S&P 500 is higher by 25.30% while BHC is higher by 17.48%. BHC lost -$3.28 per share the over the last 12 months.